
Tucanat (Tucatinib 150 mg) is a targeted anticancer medicine used for the treatment of HER2-positive breast cancer, including advanced or metastatic cases. It works by selectively inhibiting the HER2 tyrosine kinase, helping to slow cancer cell growth.
| Manufacturer | Natco |
| Generic Name | Tucatinib |
| Strength | 150mg |
| Package size | 60 Tablets |
| Used for | HER2-positive breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 Tablets | $435 | £322 | A$606 | ₱27,270 | د.ت1,266.29 | ₩582,509 | lei 1,969 | HK$3,411 | RM1,770 | ฿14,364 | S$551 | د.إ1,597.76 | ر.س1,633.43 | ر.ق1,583.84 | د.ك132.675 |
Tucatinib is a targeted therapy that blocks the HER2 protein, which drives cancer cell growth. By inhibiting HER2 signaling, it slows or stops the multiplication of cancer cells.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.